Viral infections of the respiratory tract: prevention and treatment
Identifieur interne : 000724 ( Istex/Corpus ); précédent : 000723; suivant : 000725Viral infections of the respiratory tract: prevention and treatment
Auteurs : John J. TreanorSource :
- International Journal of Antimicrobial Agents [ 0924-8579 ] ; 1994.
English descriptors
- Teeft :
- Acad, Adjuvant, Adult volunteers, Alpha interferon, Amantadine, Animal models, Antibody, Antibody response, Antibody responses, Antigenic, Antigenic drift, Antigenic variant, Antimicrob, Antimicrob agents chemother, Antimicrobial, Antimicrobial agents, Antimierobial agents, Antiviral, Antiviral activity, Antiviral agents, Arch intern, Attenuated, Attenuated influenza, Attenuated influenza vaccines, Attenuated vaccines, Attenuation, Belshe, Betts, Cell culture, Cellular proteases, Chanock, Chemother, Chimeric, Cholera, Cholera toxin, Clin, Clin microbiol, Common colds, Complete protection, Cotton rats, Dolin, Dos, Elderly persons, Engl, Envelope glycoproteins, Epidemiol, Epidemiology, Experimental animals, Field trials, Further studies, Gene segments, Genetic instability, Genome, Glycoprotein, Hayden, Healthy adults, Human immunoglobulin, Human influenza, Human parainfluenza virus type, Human rhinovirus, Immune, Immune responses, Immunization, Immunogenic, Immunogenicity, Immunoglobulin, Immunol, Infection, Influenza, Influenza epidemics, Influenza vaccine, Influenza vaccines, Influenza virus, Influenza virus infection, Influenza virus vaccine, Influenza virus vaccines, Influenza viruses, Insect cells, Interferon, International journal, Intranasal, Intranasal immunization, Intranasal interferon, Intranasally, Mechanical ventilation, Microbiol, Minor group receptor, Monoclonal, Monoclonal antibodies, Mucosal, Mutant, Mutation, Natl, Neuraminidase, Neutralizing, Neutralizing antibody, Nursing homes, Outbreak, Parainfluenza, Parainfluenza type, Parainfluenza virus, Parainfluenza viruses, Passive antibody, Passive transfer, Placebo, Proc, Proc natl acad, Prophylaxis, Protease, Protective efficacy, Protective immunity, Pulmonary histopathology, Randomized, Rat, Raven press, Reassortant, Reassortant virus vaccines, Reassortant viruses, Receptor, Receptor blockade, Recombinant, Recombinant baculovirus, Recombinant vaccinia virus, Recombinant vaccinia viruses, Replication, Resistant virus, Respiratory disease, Respiratory syncytial, Respiratory syncytial virus, Respiratory syncytial virus infection, Respiratory tract, Respiratory tract disease, Rhinovirus, Rhinovirus infection, Rhinovirus infections, Rhinovirus serotypes, Ribavirin, Ribavirin aerosol, Ribavirin treatment, Rimantadine, Sendai virus, Serotypes, Side effects, Small particle aerosol, Solid protection, Subgroup, Subunit, Subunit vaccine, Subunit vaccines, Syncytial, Syncytial virus, Tissue culture, Toxicity, Toxin, Tract disease, Treanor, Trivalent, Vaccination, Vaccine, Vaccinia, Vaccinia virus recombinants, Vaccinia viruses, Viral, Virol, Virology, Virus, Virus challenge, Virus infection, Virus replication, Virus vaccine, Virus vaccines, Wyde, Young adults, Young children.
Abstract
Abstract: The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.
Url:
DOI: 10.1016/0924-8579(94)90060-4
Links to Exploration step
ISTEX:CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Viral infections of the respiratory tract: prevention and treatment</title><author><name sortKey="Treanor, John J" sort="Treanor, John J" uniqKey="Treanor J" first="John J." last="Treanor">John J. Treanor</name><affiliation><mods:affiliation>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0924-8579(94)90060-4</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000724</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000724</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Viral infections of the respiratory tract: prevention and treatment</title><author><name sortKey="Treanor, John J" sort="Treanor, John J" uniqKey="Treanor J" first="John J." last="Treanor">John J. Treanor</name><affiliation><mods:affiliation>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">International Journal of Antimicrobial Agents</title><title level="j" type="abbrev">ANTAGE</title><idno type="ISSN">0924-8579</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994">1994</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="22">22</biblScope></imprint><idno type="ISSN">0924-8579</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0924-8579</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term><term>Adjuvant</term><term>Adult volunteers</term><term>Alpha interferon</term><term>Amantadine</term><term>Animal models</term><term>Antibody</term><term>Antibody response</term><term>Antibody responses</term><term>Antigenic</term><term>Antigenic drift</term><term>Antigenic variant</term><term>Antimicrob</term><term>Antimicrob agents chemother</term><term>Antimicrobial</term><term>Antimicrobial agents</term><term>Antimierobial agents</term><term>Antiviral</term><term>Antiviral activity</term><term>Antiviral agents</term><term>Arch intern</term><term>Attenuated</term><term>Attenuated influenza</term><term>Attenuated influenza vaccines</term><term>Attenuated vaccines</term><term>Attenuation</term><term>Belshe</term><term>Betts</term><term>Cell culture</term><term>Cellular proteases</term><term>Chanock</term><term>Chemother</term><term>Chimeric</term><term>Cholera</term><term>Cholera toxin</term><term>Clin</term><term>Clin microbiol</term><term>Common colds</term><term>Complete protection</term><term>Cotton rats</term><term>Dolin</term><term>Dos</term><term>Elderly persons</term><term>Engl</term><term>Envelope glycoproteins</term><term>Epidemiol</term><term>Epidemiology</term><term>Experimental animals</term><term>Field trials</term><term>Further studies</term><term>Gene segments</term><term>Genetic instability</term><term>Genome</term><term>Glycoprotein</term><term>Hayden</term><term>Healthy adults</term><term>Human immunoglobulin</term><term>Human influenza</term><term>Human parainfluenza virus type</term><term>Human rhinovirus</term><term>Immune</term><term>Immune responses</term><term>Immunization</term><term>Immunogenic</term><term>Immunogenicity</term><term>Immunoglobulin</term><term>Immunol</term><term>Infection</term><term>Influenza</term><term>Influenza epidemics</term><term>Influenza vaccine</term><term>Influenza vaccines</term><term>Influenza virus</term><term>Influenza virus infection</term><term>Influenza virus vaccine</term><term>Influenza virus vaccines</term><term>Influenza viruses</term><term>Insect cells</term><term>Interferon</term><term>International journal</term><term>Intranasal</term><term>Intranasal immunization</term><term>Intranasal interferon</term><term>Intranasally</term><term>Mechanical ventilation</term><term>Microbiol</term><term>Minor group receptor</term><term>Monoclonal</term><term>Monoclonal antibodies</term><term>Mucosal</term><term>Mutant</term><term>Mutation</term><term>Natl</term><term>Neuraminidase</term><term>Neutralizing</term><term>Neutralizing antibody</term><term>Nursing homes</term><term>Outbreak</term><term>Parainfluenza</term><term>Parainfluenza type</term><term>Parainfluenza virus</term><term>Parainfluenza viruses</term><term>Passive antibody</term><term>Passive transfer</term><term>Placebo</term><term>Proc</term><term>Proc natl acad</term><term>Prophylaxis</term><term>Protease</term><term>Protective efficacy</term><term>Protective immunity</term><term>Pulmonary histopathology</term><term>Randomized</term><term>Rat</term><term>Raven press</term><term>Reassortant</term><term>Reassortant virus vaccines</term><term>Reassortant viruses</term><term>Receptor</term><term>Receptor blockade</term><term>Recombinant</term><term>Recombinant baculovirus</term><term>Recombinant vaccinia virus</term><term>Recombinant vaccinia viruses</term><term>Replication</term><term>Resistant virus</term><term>Respiratory disease</term><term>Respiratory syncytial</term><term>Respiratory syncytial virus</term><term>Respiratory syncytial virus infection</term><term>Respiratory tract</term><term>Respiratory tract disease</term><term>Rhinovirus</term><term>Rhinovirus infection</term><term>Rhinovirus infections</term><term>Rhinovirus serotypes</term><term>Ribavirin</term><term>Ribavirin aerosol</term><term>Ribavirin treatment</term><term>Rimantadine</term><term>Sendai virus</term><term>Serotypes</term><term>Side effects</term><term>Small particle aerosol</term><term>Solid protection</term><term>Subgroup</term><term>Subunit</term><term>Subunit vaccine</term><term>Subunit vaccines</term><term>Syncytial</term><term>Syncytial virus</term><term>Tissue culture</term><term>Toxicity</term><term>Toxin</term><term>Tract disease</term><term>Treanor</term><term>Trivalent</term><term>Vaccination</term><term>Vaccine</term><term>Vaccinia</term><term>Vaccinia virus recombinants</term><term>Vaccinia viruses</term><term>Viral</term><term>Virol</term><term>Virology</term><term>Virus</term><term>Virus challenge</term><term>Virus infection</term><term>Virus replication</term><term>Virus vaccine</term><term>Virus vaccines</term><term>Wyde</term><term>Young adults</term><term>Young children</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.</div></front></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>vaccine</json:string><json:string>syncytial</json:string><json:string>rhinovirus</json:string><json:string>influenza</json:string><json:string>glycoprotein</json:string><json:string>antiviral</json:string><json:string>attenuated</json:string><json:string>amantadine</json:string><json:string>parainfluenza</json:string><json:string>virol</json:string><json:string>cotton rats</json:string><json:string>rimantadine</json:string><json:string>ribavirin</json:string><json:string>recombinant</json:string><json:string>reassortant</json:string><json:string>subunit</json:string><json:string>viral</json:string><json:string>receptor</json:string><json:string>antigenic</json:string><json:string>vaccinia</json:string><json:string>respiratory syncytial virus</json:string><json:string>virology</json:string><json:string>antimicrobial</json:string><json:string>treanor</json:string><json:string>antimicrobial agents</json:string><json:string>interferon</json:string><json:string>attenuation</json:string><json:string>influenza vaccine</json:string><json:string>antimicrob</json:string><json:string>chemother</json:string><json:string>virus</json:string><json:string>mutant</json:string><json:string>microbiol</json:string><json:string>immunogenic</json:string><json:string>clin</json:string><json:string>serotypes</json:string><json:string>prophylaxis</json:string><json:string>antimicrob agents chemother</json:string><json:string>virus infection</json:string><json:string>epidemiol</json:string><json:string>immunogenicity</json:string><json:string>immunization</json:string><json:string>respiratory syncytial virus infection</json:string><json:string>clin microbiol</json:string><json:string>influenza virus</json:string><json:string>neutralizing</json:string><json:string>subgroup</json:string><json:string>betts</json:string><json:string>neuraminidase</json:string><json:string>hayden</json:string><json:string>cell culture</json:string><json:string>belshe</json:string><json:string>young adults</json:string><json:string>adjuvant</json:string><json:string>antiviral activity</json:string><json:string>syncytial virus</json:string><json:string>engl</json:string><json:string>virus vaccine</json:string><json:string>genome</json:string><json:string>human parainfluenza virus type</json:string><json:string>intranasal</json:string><json:string>immunoglobulin</json:string><json:string>young children</json:string><json:string>proc natl acad</json:string><json:string>acad</json:string><json:string>natl</json:string><json:string>antiviral agents</json:string><json:string>chanock</json:string><json:string>proc</json:string><json:string>immunol</json:string><json:string>wyde</json:string><json:string>neutralizing antibody</json:string><json:string>monoclonal</json:string><json:string>subunit vaccines</json:string><json:string>placebo</json:string><json:string>dolin</json:string><json:string>intranasally</json:string><json:string>mutation</json:string><json:string>toxicity</json:string><json:string>cholera toxin</json:string><json:string>epidemiology</json:string><json:string>trivalent</json:string><json:string>randomized</json:string><json:string>mucosal</json:string><json:string>animal models</json:string><json:string>monoclonal antibodies</json:string><json:string>parainfluenza viruses</json:string><json:string>virus vaccines</json:string><json:string>tract disease</json:string><json:string>healthy adults</json:string><json:string>immune</json:string><json:string>chimeric</json:string><json:string>vaccination</json:string><json:string>replication</json:string><json:string>protective immunity</json:string><json:string>influenza virus vaccine</json:string><json:string>respiratory tract disease</json:string><json:string>rhinovirus infection</json:string><json:string>respiratory syncytial</json:string><json:string>insect cells</json:string><json:string>respiratory tract</json:string><json:string>influenza vaccines</json:string><json:string>influenza viruses</json:string><json:string>infection</json:string><json:string>influenza virus infection</json:string><json:string>intranasal interferon</json:string><json:string>envelope glycoproteins</json:string><json:string>adult volunteers</json:string><json:string>reassortant viruses</json:string><json:string>resistant virus</json:string><json:string>raven press</json:string><json:string>antigenic drift</json:string><json:string>dos</json:string><json:string>toxin</json:string><json:string>protease</json:string><json:string>reassortant virus vaccines</json:string><json:string>human rhinovirus</json:string><json:string>vaccinia viruses</json:string><json:string>attenuated vaccines</json:string><json:string>respiratory disease</json:string><json:string>experimental animals</json:string><json:string>ribavirin treatment</json:string><json:string>international journal</json:string><json:string>influenza epidemics</json:string><json:string>human influenza</json:string><json:string>attenuated influenza</json:string><json:string>recombinant vaccinia virus</json:string><json:string>sendai virus</json:string><json:string>parainfluenza type</json:string><json:string>antibody response</json:string><json:string>rhinovirus serotypes</json:string><json:string>arch intern</json:string><json:string>cholera</json:string><json:string>small particle aerosol</json:string><json:string>cellular proteases</json:string><json:string>common colds</json:string><json:string>alpha interferon</json:string><json:string>rhinovirus infections</json:string><json:string>receptor blockade</json:string><json:string>intranasal immunization</json:string><json:string>recombinant baculovirus</json:string><json:string>further studies</json:string><json:string>mechanical ventilation</json:string><json:string>pulmonary histopathology</json:string><json:string>influenza virus vaccines</json:string><json:string>human immunoglobulin</json:string><json:string>passive transfer</json:string><json:string>vaccinia virus recombinants</json:string><json:string>passive antibody</json:string><json:string>complete protection</json:string><json:string>elderly persons</json:string><json:string>subunit vaccine</json:string><json:string>recombinant vaccinia viruses</json:string><json:string>minor group receptor</json:string><json:string>nursing homes</json:string><json:string>parainfluenza virus</json:string><json:string>protective efficacy</json:string><json:string>side effects</json:string><json:string>gene segments</json:string><json:string>genetic instability</json:string><json:string>virus replication</json:string><json:string>attenuated influenza vaccines</json:string><json:string>solid protection</json:string><json:string>virus challenge</json:string><json:string>ribavirin aerosol</json:string><json:string>antibody responses</json:string><json:string>field trials</json:string><json:string>immune responses</json:string><json:string>antigenic variant</json:string><json:string>tissue culture</json:string><json:string>antimierobial agents</json:string><json:string>outbreak</json:string><json:string>rat</json:string><json:string>antibody</json:string></teeft></keywords><author><json:item><name>John J. Treanor</name><affiliations><json:string>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Respiratory viruses</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Viral vaccines</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Antiviral chemotherapy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Influenza virus</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Respiratory syncytial virus</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parainfluenza virus</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Rhinovirus</value></json:item></subject><arkIstex>ark:/67375/6H6-F6J8ZG6H-3</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Full-length article</json:string></originalGenre><abstract>Abstract: The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.</abstract><qualityIndicators><score>7.9</score><pdfWordCount>15793</pdfWordCount><pdfCharCount>101583</pdfCharCount><pdfVersion>1.2</pdfVersion><pdfPageCount>22</pdfPageCount><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>75</abstractWordCount><abstractCharCount>522</abstractCharCount><keywordCount>7</keywordCount></qualityIndicators><title>Viral infections of the respiratory tract: prevention and treatment</title><pii><json:string>0924-8579(94)90060-4</json:string></pii><genre><json:string>research-article</json:string></genre><serie><title>Virology</title><language><json:string>unknown</json:string></language><pages><first>1091</first><last>1152</last></pages></serie><host><title>International Journal of Antimicrobial Agents</title><language><json:string>unknown</json:string></language><publicationDate>1994</publicationDate><issn><json:string>0924-8579</json:string></issn><pii><json:string>S0924-8579(00)X0086-6</json:string></pii><volume>4</volume><issue>1</issue><pages><first>1</first><last>22</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1957</json:string><json:string>1960s</json:string><json:string>1918</json:string><json:string>1994</json:string><json:string>1977</json:string></date><geogName></geogName><orgName><json:string>Department of Medicine, University of Rochester School of Medicine, Rochester</json:string><json:string>US Public Health Service</json:string><json:string>Committee on Infectious Diseases</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>J. Treanor</json:string><json:string>Hong Kong</json:string><json:string>Of</json:string><json:string>J.J. Treanor</json:string><json:string>Ann Arbor</json:string><json:string>Recent</json:string></persName><placeName><json:string>Port Chalmers</json:string><json:string>Japan</json:string><json:string>New Antigenic</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>[104-106]</json:string><json:string>[215]</json:string><json:string>[253]</json:string><json:string>[250252]</json:string><json:string>[151]</json:string><json:string>[45]</json:string><json:string>[204]</json:string><json:string>[132,133]</json:string><json:string>[223]</json:string><json:string>[167]</json:string><json:string>[174,175]</json:string><json:string>[242]</json:string><json:string>[186]</json:string><json:string>[170,171]</json:string><json:string>[39,40]</json:string><json:string>[18]</json:string><json:string>[235-237]</json:string><json:string>American Academy of Pediatrics, Elk Grove Village, IL, 1992</json:string><json:string>[239]</json:string><json:string>[6]</json:string><json:string>[156]</json:string><json:string>[231]</json:string><json:string>[71]</json:string><json:string>[13,15]</json:string><json:string>[194]</json:string><json:string>[228]</json:string><json:string>[221,222]</json:string><json:string>[247]</json:string><json:string>[201]</json:string><json:string>[164]</json:string><json:string>[183]</json:string><json:string>[114,126]</json:string><json:string>[8]</json:string><json:string>[115]</json:string><json:string>[134]</json:string><json:string>[140-143]</json:string><json:string>[153]</json:string><json:string>[47,48]</json:string><json:string>[172]</json:string><json:string>[118,119]</json:string><json:string>[49,50]</json:string><json:string>[70]</json:string><json:string>Heinz et al. [262]</json:string><json:string>[206]</json:string><json:string>[177,178]</json:string><json:string>[225]</json:string><json:string>[169]</json:string><json:string>[244]</json:string><json:string>[188]</json:string><json:string>[22-24]</json:string><json:string>[91,92]</json:string><json:string>[180]</json:string><json:string>[98]</json:string><json:string>[139]</json:string><json:string>[214]</json:string><json:string>[233]</json:string><json:string>[196]</json:string><json:string>[96,97]</json:string><json:string>[150]</json:string><json:string>Dolin et al. [109]</json:string><json:string>[128,129]</json:string><json:string>[38]</json:string><json:string>[109]</json:string><json:string>[203]</json:string><json:string>[268]</json:string><json:string>[120,121]</json:string><json:string>[166]</json:string><json:string>[241]</json:string><json:string>[185]</json:string><json:string>[13,14]</json:string><json:string>[238]</json:string><json:string>[257]</json:string><json:string>[211]</json:string><json:string>[179,180]</json:string><json:string>[230]</json:string><json:string>[161-163]</json:string><json:string>[3,4]</json:string><json:string>[208]</json:string><json:string>[227]</json:string><json:string>[5]</json:string><json:string>[246]</json:string><json:string>[200]</json:string><json:string>[130,131]</json:string><json:string>[59]</json:string><json:string>[163]</json:string><json:string>[51,52]</json:string><json:string>[182]</json:string><json:string>[209,210]</json:string><json:string>[90]</json:string><json:string>[114]</json:string><json:string>[152]</json:string><json:string>[67,68]</json:string><json:string>[248,249]</json:string><json:string>[148,149]</json:string><json:string>[123,124]</json:string><json:string>[205]</json:string><json:string>[224]</json:string><json:string>[168]</json:string><json:string>[6,25-31]</json:string><json:string>[243]</json:string><json:string>[187]</json:string><json:string>[160]</json:string><json:string>[79-83]</json:string><json:string>[19,20]</json:string><json:string>[69]</json:string><json:string>[219,220]</json:string><json:string>[100-103]</json:string><json:string>[213]</json:string><json:string>[111]</json:string><json:string>[176]</json:string><json:string>[195]</json:string><json:string>[216,217]</json:string><json:string>[116,117]</json:string><json:string>[212,213]</json:string><json:string>[229]</json:string><json:string>[254,255]</json:string><json:string>[127]</json:string><json:string>[202]</json:string><json:string>[267]</json:string><json:string>[165]</json:string><json:string>[95]</json:string><json:string>[240]</json:string><json:string>[184]</json:string><json:string>[218]</json:string><json:string>[256]</json:string><json:string>[2]</json:string><json:string>[154]</json:string><json:string>[173]</json:string><json:string>[114,119,126]</json:string><json:string>[207]</json:string><json:string>[226]</json:string><json:string>[245]</json:string><json:string>[189-193]</json:string><json:string>[93,94]</json:string><json:string>[181]</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/6H6-F6J8ZG6H-3</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - pharmacology & pharmacy</json:string><json:string>2 - microbiology</json:string><json:string>2 - infectious diseases</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - biomedical research</json:string><json:string>3 - microbiology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pharmacology (medical)</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Infectious Diseases</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Microbiology (medical)</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>1994</publicationDate><copyrightDate>1994</copyrightDate><doi><json:string>10.1016/0924-8579(94)90060-4</json:string></doi><id>CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">Viral infections of the respiratory tract: prevention and treatment</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher><availability><licence><p>elsevier</p></licence></availability><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p><date>1994</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Viral infections of the respiratory tract: prevention and treatment</title><author xml:id="author-0000"><persName><forename type="first">John J.</forename><surname>Treanor</surname></persName><note type="correspondence"><p>Corresponding author. Tel. (+1-716) 275 5871; Fax. (+1-716) 442 4382</p></note><affiliation>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</affiliation></author><idno type="istex">CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265</idno><idno type="ark">ark:/67375/6H6-F6J8ZG6H-3</idno><idno type="DOI">10.1016/0924-8579(94)90060-4</idno><idno type="PII">0924-8579(94)90060-4</idno></analytic><monogr><title level="j">International Journal of Antimicrobial Agents</title><title level="j" type="abbrev">ANTAGE</title><idno type="pISSN">0924-8579</idno><idno type="PII">S0924-8579(00)X0086-6</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994"></date><biblScope unit="volume">4</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="22">22</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1994</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.</p></abstract><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Respiratory viruses</term></item><item><term>Viral vaccines</term></item><item><term>Antiviral chemotherapy</term></item><item><term>Influenza virus</term></item><item><term>Respiratory syncytial virus</term></item><item><term>Parainfluenza virus</term></item><item><term>Rhinovirus</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1994">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>ANTAGE</jid><aid>94900604</aid><ce:pii>0924-8579(94)90060-4</ce:pii><ce:doi>10.1016/0924-8579(94)90060-4</ce:doi><ce:copyright type="unknown" year="1994"></ce:copyright></item-info><head><ce:title>Viral infections of the respiratory tract: prevention and treatment</ce:title><ce:author-group><ce:author><ce:given-name>John J.</ce:given-name><ce:surname>Treanor</ce:surname><ce:cross-ref refid="COR1"><ce:sup>∗</ce:sup></ce:cross-ref></ce:author><ce:affiliation><ce:textfn>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</ce:textfn></ce:affiliation><ce:correspondence id="COR1"><ce:label>∗</ce:label><ce:text>Corresponding author. Tel. (+1-716) 275 5871; Fax. (+1-716) 442 4382</ce:text></ce:correspondence></ce:author-group><ce:date-accepted day="11" month="10" year="1993"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Respiratory viruses</ce:text></ce:keyword><ce:keyword><ce:text>Viral vaccines</ce:text></ce:keyword><ce:keyword><ce:text>Antiviral chemotherapy</ce:text></ce:keyword><ce:keyword><ce:text>Influenza virus</ce:text></ce:keyword><ce:keyword><ce:text>Respiratory syncytial virus</ce:text></ce:keyword><ce:keyword><ce:text>Parainfluenza virus</ce:text></ce:keyword><ce:keyword><ce:text>Rhinovirus</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Viral infections of the respiratory tract: prevention and treatment</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Viral infections of the respiratory tract: prevention and treatment</title></titleInfo><name type="personal"><namePart type="given">John J.</namePart><namePart type="family">Treanor</namePart><affiliation>Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA</affiliation><description>Corresponding author. Tel. (+1-716) 275 5871; Fax. (+1-716) 442 4382</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1994</dateIssued><copyrightDate encoding="w3cdtf">1994</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Abstract: The rapid discovery of specific viral agents as the cause of many acute respiratory diseases was accompanied by considerable optimism that vaccines or other control measures could be developed quickly. Subsequent experience has demonstrated that effective control of these important public health problems has been an elusive goal. However, recent exciting developments in our understanding of the molecular biology and immunology of these virusesay provide the basis for more effective strategies in the future.</abstract><subject><genre>Keywords</genre><topic>Respiratory viruses</topic><topic>Viral vaccines</topic><topic>Antiviral chemotherapy</topic><topic>Influenza virus</topic><topic>Respiratory syncytial virus</topic><topic>Parainfluenza virus</topic><topic>Rhinovirus</topic></subject><relatedItem type="host"><titleInfo><title>International Journal of Antimicrobial Agents</title></titleInfo><titleInfo type="abbreviated"><title>ANTAGE</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1994</dateIssued></originInfo><identifier type="ISSN">0924-8579</identifier><identifier type="PII">S0924-8579(00)X0086-6</identifier><part><date>1994</date><detail type="volume"><number>4</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="issue-pages"><start>1</start><end>80</end></extent><extent unit="pages"><start>1</start><end>22</end></extent></part></relatedItem><identifier type="istex">CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265</identifier><identifier type="ark">ark:/67375/6H6-F6J8ZG6H-3</identifier><identifier type="DOI">10.1016/0924-8579(94)90060-4</identifier><identifier type="PII">0924-8579(94)90060-4</identifier><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-F6J8ZG6H-3/record.json</uri></json:item></metadata></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000724 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000724 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:CF0AEA5EC113AFF52D2A3091BBC8EEC099D97265
|texte= Viral infections of the respiratory tract: prevention and treatment
}}
| This area was generated with Dilib version V0.6.33. |  |